scholarly journals Percutaneous Mitral Balloon Valvuloplasty: Technique and Results

2021 ◽  
pp. 124-132
Author(s):  
Omar Mohamed Raouf Mohamed Ahmed Elsaka ◽  
Omar Elsaka
Keyword(s):  
Mitral Valve ◽  
Mitral Stenosis ◽  
Potential Problem ◽  
Long Term Outcomes ◽  
Mitral Valvuloplasty ◽  
Inflated Balloon ◽  
Percutaneous Balloon ◽  
The Right ◽  
Effective Integration

Background: Percutaneous balloon mitral valvuloplasty is a procedure used to dilate the mitral valve in cases of rheumatic mitral stenosis. The catheter is inserted into the female vein to the right atrium and atrial septum. The mitral valve is then passed through the inflated balloon to facilitate effective integration of mitral adhesions, which increases the area of the mitral valve and decreases the rate of mitral stenosis. Mitral regurgitation is a potential problem, and thus balloon percutaneous mitral valvuloplasty (PBMV) is prevented in moderate to severe relapse. The Wilkins score studies mitral valve morphology and evaluation by echocardiography to assess the viability of PBMVs based on specific echocardiographic conditions. Conclusion: There are many factors in the immediate and long-term outcomes of patients undergoing PMV. Echo-Sc can be used in combination with other clinical and morphological predictions of PMV effects to identify patients who experience the best effects on PMV.

scholarly journals Percutaneous balloon mitral valvuloplasty in comparison with open mitral valve commissurotomy for mitral stenosis during pregnancy

2001 ◽  
Vol 37 (3) ◽  
pp. 900-903 ◽  
Author(s):  
José A.M de Souza ◽  
Eulogio E Martinez ◽  
John A Ambrose ◽  
Claudia M.R Alves ◽  
Daniel Born ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Mitral Stenosis ◽  
Mitral Valvuloplasty ◽  
Percutaneous Balloon Mitral Valvuloplasty ◽  
Percutaneous Balloon

Abstract 20155: 15-year Outcomes and Predictors of Success for Percutaneous Mitral Commissurotomy for Rheumatic Mitral Stenosis

Circulation ◽  
2014 ◽  
Vol 130 (suppl_2) ◽  
Author(s):  
AlFazir Omar ◽  
Amin Ariff ◽  
Robaayah Zambahari ◽  
Rosli Mohd Ali
Keyword(s):  
Heart Disease ◽  
Mitral Valve ◽  
Mitral Stenosis ◽  
Long Term Outcomes ◽  
Mitral Valve Area ◽  
Post Procedure ◽  
Mitral Commissurotomy ◽  
Procedural Success ◽  
Valve Area

Background: Rheumatic heart disease remains the most common acquired heart disease in children, especially in developing countries. This study aims to investigate the predictors of immediate procedural success and the immediate and long-term outcomes in patients undergoing percutaneous mitral commissurotomy (PTMC). Methods: A total of 1552 patients with rheumatic mitral stenosis and underwent PTMC from 1989 to 2012 were identified. We divided the group according to Wilkins score as low risk (≤5), intermediate risk (6-8) and high-risk (≥9). Procedural success was defined as mitral valve area greater than 1.0cm2 with a mean gradient of less than 10mmHg. Results: The median age was 36 years old [IQR 28-45]. The majority of patients was female (78.5%) and did not have any other valve involvements (85.0%). Most of cases were elective (99.5%) although 103 patients were pregnant (6.6%) during PTMC. The mitral valve area increased from 0.8cm2 [IQR 0.7-1.0] pre-procedure to 1.5cm2 [IQR 1.3-1.7] post-procedure, with a reduction in the mean pressure gradient of 15mmHg [IQR 12-20] to 4mmhg [IQR 2-6] post-procedure (all p< 0.05). Using logistic regression analysis, no difference was seen in immediate procedural success between increasing age, previous PTMC, emergency cases, New York Heart Association status, balloon size or increasing risk groups (all p>0.05). During the 15-year follow-up, the majority of patients were still alive. Conclusions: PTMC appears to be safe and effective in our population, irrespective of older age, higher NYHA class, higher Wilkins score and previous PTMC with good immediate and long-term outcomes.

Sign in / Sign up

Export Citation Format

Share Document